Default company panoramic image
Logo

Thermal Therapeutic Systems, Inc.

TTS' VERATHERM Portable Hyperthermic Perfusion System advances the therapy for abdominal carcinomatosis by delivering heated chemotherapy

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Pittsburgh, PA, USA
  • Currency USD
  • Founded July 2006
  • Employees 4
  • Website thermaltherapeutics.com

Company Summary

VERATHERM is a proprietary technology platform designed to enable physicians to immediately administer heated intraperitoneal chemotherapy (HIPEC) peri-operatively. VERATHERM is expected to provide the medical community with an economical technology which can safely and efficiently deliver temperature-dosed chemotherapy. Our product differentiation includes patent protected features for better temperature control, safety and portability. Rapid

Team

  • Default avatar
    Gardiner H F Smith
    President and CEO

    Mr. Smith joined TTS after guiding several life sciences startups through the Pittsburgh Life Sciences Greenhouse Executive Program. Prior to joining the Greenhouse, Mr. Smith was CEO and founder of TenX Biopharma, a Phase III cancer antibody company which was sold in May, 2011. He previously co-founded a consulting firm, SHI Link, of 8 professionals offering biopharma and medical device management services, including his position as interim Pres

  • Default avatar
    Joseph T Donnelly
    CFO

    Mr. Donnelly is a financial executive with 32 years of professional experience in the healthcare industry. Joe began his career with Price Waterhouse. He later joined Allegheny Health, Education & Research as the Vice President and Corporate Controller and Chief Financial Officer of Allegheny Singer Research Institute. Joe co-founded Metamorphic Surgical Devices, whose technology was acquired by the Guidant Corporation. Joe also presently serves

  • Default avatar
    Peter M DeComo
    Chairman

    Peter M. DeComo is Chairman and CEO of Alung Technologies, Inc., a company which is currently developing a revolutionary Artificial Lung technology for the treatment of respiratory failure. Pete is the former Founder, Chairman and CEO of Renal Solutions, Inc. where he raised $40 million in private equity financing and $25 million in debt financing to fund the development of Renal's innovative Allient®, sorbent-based hemodialysis system. Renal Sol

Advisors

  • Default avatar
    Pepper Hamilton, LLP
    Lawyer
    Unconfirmed
    Default avatar
    Alpern Rosnethal
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Originate Ventures
    Unconfirmed
    Default avatar
    Pittsburgh Life Sciences Greenhouse
    Unconfirmed
    Default avatar
    Innovation Works
    Unconfirmed